icon
icon
icon
icon
$300 Off
$300 Off

News /

Articles /

F5 Shares Surge 15%: Here's Why and 20 Stocks Moving Premarket

Wesley ParkWednesday, Jan 29, 2025 5:30 am ET
7min read


F5 Networks Inc. (NASDAQ: FFIV) shares have been on a roll, surging by 15% in recent trading sessions. The company's strong financial performance and strategic initiatives have driven this impressive stock price appreciation. Let's delve into the factors contributing to F5's share price increase and explore 20 other stocks moving in the premarket.



Factors Driving F5's Share Price Increase

1. Strong Revenue Growth: F5 reported a 11% increase in revenue to $766 million in the first quarter, driven by a 22% increase in software revenue and 18% growth in systems revenue. This robust top-line growth indicates a healthy business performance (Source: F5's Q1 FY2025 Earnings Release).
2. Earnings Beat: F5's earnings per share (EPS) of $3.84 beat analyst estimates of $3.36 by 14.000000000000002%. This earnings beat can drive investor confidence and lead to an increase in stock price (Source: Benzinga's Earnings Report).
3. Positive Guidance: F5 management provided guidance for Q2 2025, expecting earnings between $3.02 and $3.14 per share. This positive outlook can encourage investors to buy the stock, driving up its price (Source: Benzinga's Earnings Report).
4. Alignment with Secular Trends: F5's alignment with significant secular trends, such as hybrid multicloud and AI, positions the company for future growth. This strategic alignment can make the growth more sustainable (Source: F5's Q1 FY2025 Earnings Release).

FFIV Total Revenue (FY)


20 Stocks Moving Premarket

1. Lucas GC Limited (LGCL): Up 71.5% to $0.9812
2. 60 Degrees Pharmaceuticals, Inc. (SXTP): Up 66.1% to $1.28
3. 60 Degrees Pharma: Received IRB approval of Phase II study to examine tafenoquine for chronic babesiosis
4. Silexion Therapeutics Corp (SLXN): Up 37% to $1.85
5. Silexion Therapeutics: Shares jumped 133% on Tuesday after reporting new preclinical data for SIL-204
6. The Joint Corp (JYNT): Up 32% to $14.90
7. Faraday Future Intelligent Electric Inc. (FFIE): Up 27.4% to $1.72
8. Faraday Future: Received $30 million of previously committed financing
9. Nextracker Inc. (NXT): Up 20.5% to $47.75
10. Nextracker: Reported better-than-expected third-quarter financial results and raised its FY25 GAAP EPS guidance
11. Banzai International, Inc. (BNZI): Up 18.4% to $1.48
12. Banzai International: Recently announced the acquisition of Act-On Software
13. Centuri Holdings, Inc. (CTRI): Up 16.4% to $24.45
14. Turning Point Brands, Inc. (TPB): Up 14.4% to $68.79
15. Culp, Inc. (CULP): Down 41.9% to $3.00
16. Crown LNG Holdings Limited (CGBS): Down 24.9% to $0.3650
17. Manhattan Associates, Inc. (MANH): Down 23.4% to $225.92
18. IMAC Holdings, Inc. (BACK): Down 22.9% to $0.94
19. Haoxi Health Technology Limited (HAO): Down 22.3% to $2.86
20. First Commonwealth Financial Corporation (FCF): Down 22.1% to $13.10

pre-market percentage change(2633)
pre-market percentage change rank from largest to smallest 20(20)
pre-market trading volume(2633)
market cap(6523)
pre-market percentage change rank from largest to smallest 20 ; pre-market trading volume ; market cap(2633)
Pre-Market Percentage Change%2025.01.29
Pre-Market Percentage Change ranking2025.01.29
Pre-Market Trading Volume(Shares)2025.01.29
Market Cap(USD)2025.01.28
80.331/2633 8.42M 1.90M
68.412/2633 11.53M 42.31M
44.443/2633 2 46.98M
33.334/2633 6.74M 3.52M
30.385/2633629.19K 10.60M
27.886/2633 3168.36M
24.067/2633 3K 2.52M
22.228/2633 4.49M 68.45M
20.169/2633 8 1.72B
19.3410/2633 5 3.68B
Ticker
SXTP60 Degrees
LGCLLucas GC
CRWSCrown Crafts
SLXNSilexion
GVHGlobavend Holdings
ACTUActuate
ATCHAtlasClear Holdings
FFIEFaraday Future
STGWStagwell
ATGEAdtalem Global
View 20 resultsmore


In conclusion, F5's strong revenue growth, earnings beat, positive guidance, and alignment with secular trends have contributed to its 15% share price increase. Additionally, the 20 stocks moving premarket offer a mix of gainers and losers, with various factors driving their performance. Investors should stay informed about these trends and consider the underlying fundamentals when making investment decisions.
Comments

Add a public comment...
Post
User avatar and name identifying the post author
Outrageous-Rate-4080
01/29
F5's software rev growth is 🔥. Betting on their hybrid cloud strategy seems wise. Anyone else bullish on $FFIV?
0
Reply
User avatar and name identifying the post author
Keroro999
01/29
Centuri's 16% pop is nice, but I'm cautious. Energy sector volatility keeps me on edge. Diversification's key, folks.
0
Reply
User avatar and name identifying the post author
provoko
01/29
@Keroro999 What's your energy pick?
0
Reply
User avatar and name identifying the post author
Medical-Truth-3248
01/29
Nextracker's earnings beat, considering a small position.
0
Reply
User avatar and name identifying the post author
Plane-Salamander2580
01/29
@Medical-Truth-3248 How long you planning to hold Nextracker?
0
Reply
User avatar and name identifying the post author
gameon-manhattan
01/29
Silexion's preclinical data boosted SIL-204. Holding long.
0
Reply
User avatar and name identifying the post author
WoodKite
01/29
@gameon-manhattan How long you planning to hold Silexion? Curious if you're thinking short-term flip or long-term play.
0
Reply
User avatar and name identifying the post author
Ogulcan0815
01/29
@gameon-manhattan I had Silexion in my portfolio last year, sold too early. Regret not holding when they dropped those preclinical results. FOMO hitting hard now.
0
Reply
User avatar and name identifying the post author
JobuJabroni
01/29
F5's software revenue is 🔥. Betting on their hybrid cloud strategy seems smart. Who else is holding $FFIV for the long haul?
0
Reply
User avatar and name identifying the post author
vdeventa
01/29
60 Degrees Pharma's tafenoquine data looks promising. 📈
0
Reply
User avatar and name identifying the post author
CALAND951
01/29
@vdeventa Tafenoquine's data looks solid, but let's see if 60 Degrees can replicate these results in later trials.
0
Reply
User avatar and name identifying the post author
Mojojojo3030
01/29
Silexion's SIL-204 data looks promising. Preclinical stage but worth watching. Might be a future biotech powerhouse. Thoughts?
0
Reply
User avatar and name identifying the post author
dypeverdier
01/29
@Mojojojo3030 What do you think about their competitive landscape?
0
Reply
User avatar and name identifying the post author
Keroro999
01/29
60 Degrees Pharma's tafenoquine news is big. Could be a game-changer for babesiosis treatment. Anyone else seeing potential here?
0
Reply
User avatar and name identifying the post author
SnowShoe86
01/29
Banzai International's Act-On Software acquisition could boost their marketing tech game. Keeping an eye on $BNZI for now. 📈
0
Reply
User avatar and name identifying the post author
NoAd7400
01/29
Nextracker's solar tracker tech is dope. Watching $NXT for more gains. Renewable energy is the future, fam.
0
Reply
User avatar and name identifying the post author
Charming_Raccoon4361
01/29
F5's software growth is 🔥, but watch the guidance.
0
Reply
User avatar and name identifying the post author
CertifiedWwDuby
01/29
@Charming_Raccoon4361 Watch guidance? Already did. F5 nailed it.
0
Reply
User avatar and name identifying the post author
NavyGuyvet
01/29
Nextracker's EPS guidance raise is a good sign. Solid performance in renewables. Consider adding $NXT to your clean energy portfolio?
0
Reply
User avatar and name identifying the post author
BlackBlood4567
01/29
@NavyGuyvet I had NXT on my radar, but didn't pull the trigger. Now I'm FOMO-ing hard. Should've listened to my gut.
0
Reply
User avatar and name identifying the post author
Senyorty12
01/29
@NavyGuyvet How long you planning to hold NXT? Curious if you're thinking short-term flip or long-term play.
0
Reply
Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.
You Can Understand News Better with AI.
Whats the News impact on stock market?
Its impact is
fork
logo
AInvest
Aime Coplilot
Invest Smarter With AI Power.
Open App